Novel Nano vaccine to treat skin cancer/melanoma

Vaccines & Vaccinology : Novel Nano vaccine for Melanoma

Researchers have developed a novel Nano-vaccine for melanoma, the most aggressive type of skin cancer that begins in melanocytes. Their experiments have proven effective in preventing the development of melanoma and in treating primary tumours and metastases that result from melanoma. The focus of the research was on a nanoparticle that serves as the basis for the new vaccine.
Melanoma develops in the skin cells, which is called the melanocytes, produce melanin or skin pigment. The fight against skin cancer/melanoma is becoming advanced over the years through a variety of treatment modalities & experiments, such as immunotherapy, radiation therapy & chemotherapy, but the vaccine approach, which has a great effect against various viral diseases, has not materialized yet against cancer. Scientists have shown that it is possible to produce an effective Nano-vaccine against melanoma/skin cancer and to sensitize the immune system to immunotherapies.
The researchers harnessed tiny particles, about 170 nanometres in size, made of a biodegradable polymer. Within each particle, two peptide short chains of amino acids are packed, which are expressed in melanoma cells. They the nanoparticles was injected (Nano Vaccines) into a mouse model bearing melanoma.
The nanoparticles acts just like known vaccines for viral-borne diseases. The scientists stimulated the immune system of the mice, and the immune cells learned to identify and attack cells containing the two peptides, that is, the melanoma cells. This meant that, the immune system of the immunized mice will attack melanoma cells if and when they appear in the body. The researchers then examined the effectiveness of the vaccine under three different conditions & they found the positive result in all the cases.
Firstly, they saw that vaccines have prophylactic effects. The vaccine was injected into healthy mice, and an injection of melanoma cells followed. The result was that the mice did not get sick, that means the vaccine prevented the disease.
Secondly, the nanoparticle was used to treat a primary tumour, i.e., a combination of the innovative vaccine and immunotherapy treatments were tested on melanoma model mice. The synergistic treatment significantly delayed the progression of the disease and greatly extended the lives of all treated mice.
Finally, the researchers validated their approach on tissues taken from patients with melanoma brain metastases. This suggested that the Nano-vaccine can be used to treat brain metastases as well.

Comments

Post a Comment

Popular posts from this blog

Petting zoos transmit Virulent drug-resistant bacteria to visitors

Image
Human infectious diseases :  Petting zoos transmit Virulent drug-resistant bacteria to visitors Petting zoos are a popular attraction around the world, allowing direct and indirect exposure of both children and adults to a diverse range of animal species. They are different from regular zoos because rather than visitors just looking at the animals, petting zoos are interactive with children visiting, holding and petting the animals. Extended spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacteriaceae (AmpC-E), which are resistant to a number of commonly used antibiotics, have become a matter of great concern in both human and veterinary medicine, so understanding the likelihood of them colonizing the animals is critical to evaluating the risk that may be posed to visitors. The researchers did a survey across randomly chosen petting zoos geographically distributed throughout the world, taking samples of faecal matter as well as from the body surface (skin, fur, or ...
Read more

How to block new antibiotic resistance gene???

Image
A new antimicrobial-resistance gene, VCC-1, a ß-lactamase gene, has been discovered in benign close relatives of virulent Vibrio cholerae, which causes cholera. Now, researchers have found a way to block the VCC-1 enzyme, which disables that resistance gene. The research is published in the journal Antimicrobial agents & chemotherapy . VCC-1 was first found in Canada, by investigators from the Public Health Agency of Canada, on frozen shrimp that had been imported from India, and sold in a Canadian grocery store. A handful of other ß-lactamase resistance genes have also emerged from India. ß-lactamase genes code for enzymes that can break down ß-lactams, which are a critically important class of antimicrobials . The researchers identified the gene in a non-toxigenic strain of Vibrio cholerae. Since then, VCC-1 has also been found in non-toxigenic V. cholerae off of the German coastline. The danger is that it's a short jump for a gene from non-toxigenic V. cholerae to...
Read more

How the mode of delivery plays key role in shaping the child's skin microbiome?

Image
Microbial Virulence : Key roles in shaping the child's skin microbiome.. The maturation of skin microbial communities during childhood is important for the skin of the children and development of the immune system into adulthood, but only a few studies have analyzed the presence of microbiota in young children. Recently investigators in China found that bacterial genera in children were more similar to those of their own mothers than to those of unrelated women. They suggest that the mode of delivery at birth could be an important factor in shaping the child's microbiome. To date, research into the maternal influence on her child's skin microbiome has been mostly limited to a narrow postpartum window in children younger than one year old and fewer studies have explored the maternal relationship with the child's microflora after infancy explained by chinese investigators. Therefore, we expanded the scope of our analysis to include sampling from different bod...
Read more